Immunotherapy impact factor 2020
Witryna1 dzień temu · Impact factor 6.693 (2024) Five year impact factor 8 days Submission to first decision (Median) 828,104 (2024) Downloads. Latest issue. Volume 72. Issue 4, … WitrynaIn vivo experiments showed that Anlotinib was more effective in the treatment of GSDMB-positive bladder cancer than GSDMB-negative bladder cancer. Anlotinib can increase the secretion of antitumor-related factors in GSDMB-positive bladder cancer such as TNF-a and CD107a. In addition, Anlotinib also induced an increase in GSDMB protein …
Immunotherapy impact factor 2020
Did you know?
WitrynaLiczba wierszy: 13 · Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer … WitrynaMonoclonal Antibodies in Immunodiagnosis and Immunotherapy is a peer-reviewed venue for promoting and sharing research rooted in hybridoma technology. ... three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric. Cites per document ... 2024: 1.367: Cites ...
WitrynaAccording to the Journal Citation ReportsTM (JCR) from ClarivateTM, 2024, Impact Factors for the AACR Journals: Journal. Impact Factor. Cancer Discovery. 38.272. Cancer Epidemiology, Biomarkers & Prevention. 4.090. … Witryna27 maj 2024 · The impact score (IS) 2024 of Monoclonal Antibodies in Immunodiagnosis and Immunotherapy is 1.61, which is computed in 2024 as per its definition.Monoclonal Antibodies in Immunodiagnosis and Immunotherapy IS is increased by a factor of 0 and approximate percentage change is 0% when …
Witryna13 kwi 2024 · The aim of this study is to evaluate the factors affecting the objective response rate (ORR) after neoadjuvant therapy of taxol plus platinum (TP) regimen … WitrynaJournal Announcements. JITC's latest Impact Factor of 12.485 was announced in the 2024 Journal Citation Reports (JCR), placing the journal in the top 12% of the …
WitrynaImmunotherapy Impact Factor by Web of Science. Index. SCIE/SSCI Impact Factor. 4.196 by WOS ... 2024 Impact Factor . 3.05 3.114 3.231. 2024 Impact Factor . 2.551 2.7 2.683. 2024 Impact Factor . 2.615 2.678 2.588. ... Impact Factor. Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles …
Witrynav.2 (Suppl 3) 2014. Vol. 1. 2013. v.1. 2013. v.1 (Suppl 1) 2013. Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group. earnersfxWitryna27 maj 2024 · The impact score (IS) 2024 of Journal of Immunotherapy is 4.69, which is computed in 2024 as per its definition.Journal of Immunotherapy IS is increased by a factor of 0.39 and approximate percentage change is 9.07% when compared to preceding year 2024, which shows a rising trend. The impact score (IS), also denoted … earners furnitureWitrynaArticle of the Year 2024. Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy. Read the full article. ... This result was also confirmed by a … earnersoptionWitrynaRecent advances in immunotherapies against infectious diseases. Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity. Behind the scenes … csvwriter utf bomWitryna13 kwi 2024 · The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance … earners appliance centerWitrynaLiczba wierszy: 13 · Immunotherapy Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 1750-743X. Immunotherapy Impact Factor IF … csvwriter writefieldWitryna11 kwi 2024 · The aim of Human Vaccines & Immunotherapeutics is to provide a platform to present and discuss developments in vaccinology and immunotherapy. The journal covers the following topics: Research and development of novel vaccines and immunotherapeutics. Experimental vaccines and novel approaches in vaccination and … earners crib